EASD 2025 15 - 19 September 2025

Pharmacokinetics, safety and tolerability of amycretin in people with renal impairment

Authors :

Sine Pfeiffer Haugaard¹; Tobias Karlsson¹; Victoria Kegel-Hübner²; Lykke Ida Kaas Oldenburg¹; Mahera Parwez³; Christoffer Wiingaard¹; Anne Flint¹

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Keywords

Obesity

Congress oral presentation

GLP-1 RA

Amylin

Amycretin

PHASE 1 (RCT)